<DOC>
	<DOCNO>NCT01599442</DOCNO>
	<brief_summary>Diabetic foot syndrome ( DFS ) disease cause neurogenic ( concern nervous system ) , vascular , mechanic metabolic factor , complicate impairment immune system correspond increase risk infection . Results clinical trial efficacy intervention aim reduce number patient-relevant end point limited comparability due heterogenity patient characteristic . By nature , randomize clinical trial ( RCT ) focus limited section wide range possible intervention regime . In clinical practice , however , number patient dfs never part clinical trial . Furthermore , contemporary register indication conclusion regard comparative merit different therapeutic strategy may draw . The register conceive find extent RCT patient representative overall patient collective dfs critical limb ischemia evaluate therapeutic success treatment strategy . An RCT ass efficacy urokinase versus placebo imbed register .</brief_summary>
	<brief_title>Register Patients With Diabetic Foot Syndrome Critical Limb Ischemia</brief_title>
	<detailed_description>August-1 register find extent RCT patient representative overall patient collective dfs critical limb ischemia evaluate therapeutic success treatment strategy . An RCT ass efficacy urokinase versus placebo imbed register .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Ischemia</mesh_term>
	<mesh_term>Diabetic Foot</mesh_term>
	<criteria>diabetic patient dfs critical limb ischemia age 18 old less 1 year life expectancy prior major amputation plan major expectation prior treatment current episode dfs urokinase mechanical heart valve replacement cerebral event change CT last three month nonremediated proliferate retinopathy uncontrolled hypertension ( systolic &gt; 180 mmHg , diastolic &gt; 100 mmHg ) hemorrhagic diathesis ( spontaneous quick value &lt; 50 % , spontaneous ptt &gt; 40 sec , thrombocytes &lt; 100 gpt/l ) acute gastrointestinal bleeding ulcer last 4 week prior reverse bypass operation concomitant participation clinical trial insufficient compliance premenopausal woman use safe method contraception ( i. e. IUD , hormone implant , hormone depot injection , combine pill ( estrogens gestagens ) , vaginal ring vasectomized partner ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2014</verification_date>
</DOC>